Shared Resources Core
Shared Resources Core
批准号:
10732989
负责人:
FENG CHEN
金额:
$14.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-30 至 2028-07-31
关键词:
ATAC-seqAddressAnatomyAtlasesBioinformaticsBiological AssayBiological MarkersCellsCharacteristicsClinicalComplexDNADataDevelopmentDrug resistanceEffectivenessEnsureFutureGenitourinary systemGenomicsGoalsHeterogeneityHumanImageImmunofluorescence ImmunologicIndividualInfrastructureMapsMissionModelingMolecularMolecular ProfilingMonitorOncogenesPredictive ValueProceduresProductivityProteinsProteomicsRNAResearchResearch DesignResearch Project GrantsResistanceResolutionResource SharingResourcesSamplingServicesSpeedStainsStandardizationStromal CellsStructureSupervisionSurveysTechnologyTestingTissuesTreatment outcomeUnited States National Institutes of HealthUniversitiesValidationVisualizationWashingtonWorkbiomarker identificationcancer genomeclinical imagingcostexome sequencinggenome sequencingimprovedin vivoindividual responsemolecular imagingmultiple omicsneoplastic cellnew technologypatient derived xenograft modelpatient engagementphosphoproteomicspotential biomarkerpre-clinicalprogramsradiological imagingsenescencesingle nucleus RNA-sequencingstress reductiontargeted imagingtherapy resistanttooltraittranscriptometranscriptome sequencingtranscriptomicstreatment responsetumortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SHARED RESOURCES CORE: SUMMARY
The Shared Resources Core (SRC) is structured as a physical shared resource that will support both Research
Projects, the PDX Core, as well as pilot and trans-Network projects. The most critical goal of the SRC is to
provide services and resources that are either unavailable to individual research teams within PDXNet or that
are unable to meet the cost, technical, and speed requirements of the Projects and other components at WU-
PDTC. Other important missions for the SRC include optimization of the procedures for project/sample-specific
requirements, standardization of the assays to ensure data consistency, and incorporation of the latest
technologies. This centralized arrangement takes full advantage of the expertise and infrastructure existing at
our institute developed through participation in several large-scale NIH consortia, including HTAN (Human Tumor
Atlas Network), SenNet (Senescence Network), GUDMAP (GenitoUrinary Development Molecular Anatomy
Project), CPTAC (Clinical Proteomic Tumor Analysis Consortium), PE-CGS (Participant Engagement and
Cancer Genome Sequencing), CRIP (Co-Clinical Imaging Research Program), and PDXNet, in order to increase
effectiveness and efficiency, avoid duplicated effort, and reduce stress on individual projects. SRC will be tightly
integrated with the Research Projects, Pilot and Trans-Network Projects, the PDX Core, and the Bioinformatics
Core under the supervision of the Administrative Core. Detailed characterization of the PDX tumors at the DNA,
RNA, and protein levels will be important for validation, model selection, revelation of molecular changes in
response to treatment, illustration of mechanisms of treatment resistance, as well as the identification of
biomarkers and targets for future treatment testing. To accomplish these goals, the SRC will work with the
Research Projects and other Cores to perform two main types of assays: Omics and imaging. For omics, the
SRC will cover bulk and single cell omics, including whole exome sequencing (WES), bulk RNA-seq, single
nucleus RNA-seq and ATAC-seq (snRNA-seq and snATAC-seq), spatial transcriptomics (Visium), as well as
global proteomics and phospho-proteomics. For imaging, the SRC covers multiplex target imaging
(CODEX/Phenocycler), in vivo preclinical molecular and radiologic imaging, and standard immunofluorescence
(IF) staining. The SRC is also tasked with adjusting to the changing needs of the projects as well as introducing
new technologies and tools to assist the Projects and to accomplish the mission of the center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
-
批准号:10544995
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2022
-
负责人:FENG CHEN
-
依托单位:
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
-
批准号:10367242
-
项目类别:
-
资助金额:$48.15万
-
财政年份:2022
-
负责人:FENG CHEN
-
依托单位:
Creating high-resolution multi-omics molecular atlases for developing urogenital organs
-
批准号:10356306
-
项目类别:
-
资助金额:$47.24万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
WU-SN-TMC Bio-Analysis Core
-
批准号:10376527
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)
-
批准号:10376523
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Creating high-resolution multi-omics molecular atlases for developing urogenital organs
-
批准号:10491224
-
项目类别:
-
资助金额:$46.64万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
WU-SN-TMC Bio-Analysis Core
-
批准号:10685428
-
项目类别:
-
资助金额:$82.65万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)
-
批准号:10685417
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Creating high-resolution multi-omics molecular atlases for developing urogenital organs
-
批准号:10673765
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Pathogenic Variant Discovery Across a Broad Spectrum of Human Diseases
-
批准号:9376872
-
项目类别:
-
资助金额:$55.48万
-
财政年份:2017
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8041896
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8309407
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8512587
-
项目类别:
-
资助金额:$30.13万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8146929
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8702154
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:8286427
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:7654047
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:7799784
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:8056001
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
Calcineurin in Congenital Urinary Tract Obstruction
-
批准号:7380063
-
项目类别:
-
资助金额:$30.07万
-
财政年份:2005
-
负责人:FENG CHEN
-
依托单位:
海外基金